Cancer care cannot be equitable without access to safe, high-quality surgery.
In Chicago on a May evening, surgical oncologist Syed Nabeel Zafar received the 2026 Global Oncology Yvonne Award — a recognition that quietly reframes what oncological leadership means. Trained across Karachi, Harvard, and Houston, Zafar has spent his career insisting that the right to surgery is inseparable from the right to cancer care, and that equity is not an aspiration but an infrastructure problem. His work asks a question the field is only beginning to answer: what good is a cure if the operating room is unreachable?
- Across the world, patients with treatable cancers are dying not for lack of medicine, but for lack of a surgeon — a crisis that Zafar has made the center of his life's work.
- His DOD-funded AI navigator project targets one of oncology's most stubborn failures: pancreatic cancer patients who fall through the cracks before they ever reach an operating table.
- By directing global oncology programs, chairing international surgery committees, and building surgical capacity in sub-Saharan Africa, Zafar is assembling the infrastructure that individual brilliance alone cannot create.
- The Yvonne Award arrives as a signal from the field itself — that surgical oncology must be counted as essential global health infrastructure, not a specialty reserved for well-resourced systems.
- With 8,300+ citations, an h-index of 48, and partnerships spanning continents, Zafar's career lands as a proof of concept: that clinical precision and systems equity can be built into the same career.
On the evening of May 29 in Chicago, Syed Nabeel Zafar received the 2026 Global Oncology Yvonne Award — recognition not merely of surgical skill, but of a career organized around a single conviction: that cancer care cannot be equitable without access to safe, high-quality surgery.
Zafar's journey began in Karachi, where he earned his medical degree from Aga Khan University before moving to the United States for advanced training. He studied public health at Harvard with a focus on quantitative methods, then moved through Howard University Hospital, the University of Maryland, and finally MD Anderson Cancer Center — each institution adding not just technical depth but a sharper understanding of how health systems either open or close the door to care.
Since 2020, he has served as Assistant Professor of Surgical Oncology at the University of Wisconsin, and since 2022 as Director of the Global Oncology Program at the Carbone Cancer Center. In that role, he has built international partnerships, directed a Robotic HPB/GI Surgical Oncology Program, and led research spanning pancreatic cancer outcomes, machine learning, and health disparities. A current Department of Defense-funded project is developing an AI-assisted nurse navigator system to reduce barriers to pancreatic cancer care — one of several efforts to make the path from diagnosis to surgery shorter and more equitable.
His reach extends beyond Madison. He chairs the Quality Improvement Workgroup for the American College of Surgeons' Ethiopia Hub, leads the Global Affairs Committee of the Association of Academic Surgery, and sits on the Lancet Commission on Global Surgical Oncology Part 2 — placing him within the movement to establish surgical capacity as foundational to cancer control worldwide.
The Yvonne Award, presented by OncoDaily, honored this integration of clinical excellence, research rigor, and sustained institutional commitment. It was a recognition that the future of global oncology belongs to leaders who understand that defeating cancer requires not only drugs and radiation, but operating rooms, trained hands, outcome data, and the partnerships that carry knowledge across borders.
On a May evening in Chicago, Syed Nabeel Zafar stood to receive the Global Oncology Yvonne Award, an honor that recognized not just a surgeon's technical skill but a career built across continents in pursuit of a single conviction: that cancer care cannot be equitable without access to safe, high-quality surgery.
Zafar's path to this recognition began in Karachi, Pakistan, where he earned his medical degree from Aga Khan University before moving to the United States to pursue advanced training. He studied public health at Harvard, focusing on quantitative methods—a choice that would shape everything that followed. His surgical training took him through Howard University Hospital in Washington, DC, where he served as Administrative Chief Resident, then to the University of Maryland for advanced work in minimally invasive surgery, and finally to MD Anderson Cancer Center in Houston for specialized training in complex surgical oncology. Each step added layers: technical expertise in the operating room, but also a deepening understanding of how systems either enable or obstruct patient access to care.
Since 2020, Zafar has worked as an Assistant Professor of Surgical Oncology at the University of Wisconsin School of Medicine and Public Health in Madison. Two years later, he took on the role of Director of the Global Oncology Program at the university's Carbone Cancer Center, a position that formalized what had already become his life's work: building international partnerships, strengthening cancer care delivery systems, and addressing the vast disparities that determine whether a patient with pancreatic cancer receives timely surgery or arrives too late. He also directs the Robotic HPB/GI Surgical Oncology Program, bringing advanced surgical techniques to patients with gastrointestinal and liver cancers.
His research portfolio reflects this same integration of clinical precision and systems thinking. With more than 8,300 citations and an h-index of 48, Zafar's work spans pancreatic cancer outcomes, machine learning applications in surgery, and quality improvement across health systems. Currently, he leads a Department of Defense-funded project developing an artificial intelligence-assisted nurse navigator system designed to reduce barriers to pancreatic cancer care and address health disparities. He has also directed NIH-funded research on machine learning to predict surgical outcomes and led efforts to build surgical capacity in sub-Saharan Africa through the Wisconsin Idea Endowment.
The honors accumulated along the way—Resident of the Year at Howard, Outstanding Resident in Laparoscopic Surgery from the Society of Laparoscopic Surgery, Fellowship awards from MD Anderson, recognition from the Society of Asian Academic Surgeons, and the UW Health Rising Star Leadership award in 2025—each marked a step in a career that refused to separate technical excellence from equity. He holds fellowships in both the Society of Surgical Oncology and the American College of Surgeons, positions that reflect standing within the field.
Beyond his institutional roles, Zafar chairs the Quality Improvement Workgroup for the American College of Surgeons' Ethiopia Hub and serves as Chair of the Global Affairs Committee of the Association of Academic Surgery. He is also a member of the Lancet Commission on Global Surgical Oncology Part 2, work that places him within a growing movement to define surgical oncology as essential infrastructure for global cancer control. In regions where late diagnosis is common, where operating rooms lack basic equipment, and where trained surgical oncologists are scarce, the absence of accessible surgery means that even patients who survive to diagnosis often cannot access the care that might save their lives.
The Yvonne Award, presented by OncoDaily at its 2026 ceremony in Chicago on May 29, recognized this integration of clinical excellence, research rigor, and sustained commitment to systems change. It was not simply an individual honor. It was recognition that the future of global oncology depends on leaders who understand that cancer control requires not just drugs and radiation, but also the capacity to operate safely, the data systems to track outcomes, the training programs to build local expertise, and the partnerships that allow knowledge and technique to flow across borders. Zafar's career models what that looks like in practice.
Notable Quotes
His career reflects the reality that global oncology is built through training programs, quality improvement, data systems, surgical capacity, mentorship, and long-term partnerships.— OncoDaily reporting on Dr. Zafar's approach
The Hearth Conversation Another angle on the story
Why does a surgical oncologist need public health training? Isn't surgery just surgery?
Surgery is only part of the answer. A patient with pancreatic cancer needs a surgeon, yes, but they also need to know they have cancer early enough to operate, to reach a hospital that can do the surgery safely, to have a trained team ready. Public health training teaches you to think about systems—who gets diagnosed, who doesn't, why, and how to change it.
You've worked in the United States, Pakistan, and across Africa. What's the biggest difference in what patients face?
In the U.S., the bottleneck is often complexity—how do we do the most advanced surgery with the best outcomes? In much of the world, the bottleneck is access itself. A patient might travel for days to reach a surgeon, only to find the operating room isn't equipped, or there's no anesthesiologist, or the surgeon has never done that particular operation. Late diagnosis is common because screening doesn't exist.
Your current work involves artificial intelligence and nurse navigators. How does that address disparities?
A nurse navigator can help a patient understand their diagnosis, connect them to care, remove barriers like transportation or language. AI can help predict who's at highest risk, who might be lost to follow-up, where the system is failing. Together, they create a pathway that doesn't depend on a patient knowing exactly what to do or having resources we assume everyone has.
You have 8,300 citations. That's a lot of influence. Does that change how you approach the work?
It means people are listening. But citations are only meaningful if they lead to change—if a hospital in Ethiopia uses your quality improvement framework, if a surgeon in Pakistan adopts a technique you've published, if a patient gets better care because of something you discovered. That's the real measure.
What does it mean to you that surgical oncology is being recognized as essential to global cancer control?
For decades, surgery was sometimes treated as secondary—something you did after chemotherapy or radiation. But cancer is a surgical disease. You can't cure most solid tumors without removing them. In low-resource settings, that's often the only tool available. Recognizing surgery as essential means funding it, training for it, building infrastructure for it. It means cancer control is incomplete without it.